Article 13
United Kingdom
The programmes for the monitoring of transmissible spongiform encephalopathies (TSEs) presented by Belgium, the Czech Republic, Denmark, Germany, Estonia, Greece, Spain, France, Ireland, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2007 to 31 December 2007.
The financial contribution by the Community shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for the implementation of those programmes and shall not exceed:
EUR 2 084 000 for Belgium;
F1EUR 1 320 000 for the Czech Republic;
EUR 1 950 000 for Denmark;
EUR 11 307 000 for Germany;
EUR 233 000 for Estonia;
EUR 1 650 000 for Greece;
EUR 9 100 000 for Spain;
EUR 24 815 000 for France;
EUR 6 410 000 for Ireland;
EUR 3 000 000 for Italy;
EUR 530 000 for Cyprus;
EUR 312 000 for Latvia;
EUR 645 000 for Lithuania;
EUR 146 000 for Luxembourg;
EUR 784 000 for Hungary;
EUR 90 000 for Malta;
EUR 5 112 000 for the Netherlands;
EUR 1 759 000 for Austria;
EUR 244 000 for Poland;
EUR 2 940 000 for Portugal;
EUR 308 000 for Slovenia;
EUR 610 000 for Slovakia;
EUR 839 000 for Finland;
EUR 2 020 000 for Sweden;
EUR 6 781 000 for the United Kingdom.
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be for the tests performed and the maximum amount shall not exceed:
EUR 6 per test, for tests carried out in bovine animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 30 per test, for tests carried out in ovine and caprine animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 50 per test, for tests carried out in cervids animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 145 per test, for primary molecular discriminatory tests carried out as referred to in Annex X, Chapter C, point 3.2(c)(i) to Regulation (EC) No 999/2001.